On February 25, the Belgian Privacy Commission published an opinion (source document in French) on cloud computing in a hospital setting...

The 2025 HIMSS Global Health Conference is an annual event that attracts thousands of digital health professionals chasing cutting-edge health solutions.

In a welcome move, on 1 April 2019 the U.S. Food and Drug Administration (FDA) proposed reducing regulatory requirements for a number of radiation-emitting electronic products.

During this webinar, Kirian Claeyé and Bart Junior Bollen guide you through the eagerly anticipated reform of the reimbursement procedures for medicines in Belgium.

New innovations include connected remote monitoring devices, patient engagement tools, Artificial Intelligence (AI)-based automated detection and diagnosis, and smart operating rooms.

This regular update (no. 53 | 28 June 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines...

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion.

This regular update (no. 23 | 29 September 2020) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices ...

In a significant step towards implementing its American Patients First blueprint for lowering prescription drug prices and patient out-of-pocket costs

While we have, in some ways, moved beyond the pandemic, mental health continues to grow in importance as a workplace issue, and indeed as an issue in society at large.

The European Medicines Agency (EMA) has committed early patient access to new medicines, particularly those that target an unmet medical need or are of major public health interest.

On 4 June, the Council of the European Union (Council) adopted its negotiation position on the proposals for a new regulation and directive that make up the so-called ‘pharma package'.

This regular update (no. 55 | 12 July 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices...

This regular update (no. 44 | 21 April 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical ..

This regular alert covers key regulatory EU developments related to the COVID-19 situation. It does not purport to provide an exhaustive overview of developments and contains no analysis or opinion

This regular update (no. 56 | 19 July 2021) covers key regulatory EU developments related to the evolving COVID-19 situation (Antitrust & State Aid; Trade/Export Controls; Medicines, Medical Devices...

Under Article 4 of the Directive, a person injured by a defective product should prove the damage, the defect and the causal relationship between defect and damage.

The European Commission has adopted Commission Delegated Directive (EU) 2023/1526, which amends Directive 2011/65/EU of the European Parliament and European Council...

Food company Mowi Poland successfully challenged the European Commission's new hygiene rules governing ‘stiffening'—a specialised fish processing technique—on the grounds...

Articles 95, § 3-5 (works), 127 (supplies) and 160 (services) of the Royal Decree of 14 January 2013 regarding the general rules for execution of public tenders...